• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Characterization of an extremely large, ligand-induced conformational change in plasminogen.

作者信息

Mangel W F, Lin B H, Ramakrishnan V

机构信息

Biology Department, Brookhaven National Laboratory, Upton, NY 11973.

出版信息

Science. 1990 Apr 6;248(4951):69-73. doi: 10.1126/science.2108500.

DOI:10.1126/science.2108500
PMID:2108500
Abstract

Native human plasminogen has a radius of gyration of 39 angstroms. Upon occupation of a weak lysine binding site, the radius of gyration increases to 56 angstroms, an extremely large ligand-induced conformational change. There are no intermediate conformational states between the closed and open form. The conformational chang is not accompanied by a change in secondary structure, hence the closed conformation is formed by interaction between domains that is abolished upon conversion to the open form. This reversible change in conformation, in which the shape of the protein changes from that best described by a prolate ellipsoid to a flexible structure best described by a Debye random coil, is physiologically relevant because a weak lysine binding site regulates the activation of plasminogen.

摘要

相似文献

1
Characterization of an extremely large, ligand-induced conformational change in plasminogen.
Science. 1990 Apr 6;248(4951):69-73. doi: 10.1126/science.2108500.
2
Conformation of Lys-plasminogen and the kringle 1-3 fragment of plasminogen analyzed by small-angle neutron scattering.
Biochemistry. 1991 Apr 23;30(16):3963-9. doi: 10.1021/bi00230a023.
3
Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.有证据表明,无配体的人纤溶酶原的构象是通过kringle 5的赖氨酸结合位点与N端肽之间的分子内相互作用来维持的。
Biochem J. 1998 Jul 1;333 ( Pt 1)(Pt 1):99-105. doi: 10.1042/bj3330099.
4
Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change.两个弱赖氨酸结合位点的正向协同结合控制着谷氨酸 - 纤溶酶原的构象变化。
Biochem J. 1992 Jul 15;285 ( Pt 2)(Pt 2):419-25. doi: 10.1042/bj2850419.
5
Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.单链尿激酶型纤溶酶原激活剂:作用机制及溶栓特性
Semin Thromb Hemost. 1987 Apr;13(2):152-9. doi: 10.1055/s-2007-1003486.
6
Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.尿激酶受体介导的纤溶酶原激活复合物的组装涉及尿激酶和纤溶酶原之间直接的、非活性位点的相互作用。
Biochemistry. 1999 Jan 12;38(2):651-9. doi: 10.1021/bi981714d.
7
Conformational studies of human plasminogen and plasminogen fragments: evidence for a novel third conformation of plasminogen.人纤溶酶原及纤溶酶原片段的构象研究:纤溶酶原存在新型第三种构象的证据
Biochemistry. 1994 Mar 29;33(12):3599-606. doi: 10.1021/bi00178a017.
8
Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.在氨甲环酸存在的情况下,尿激酶将人纤溶酶原的蛋白水解修饰形式(赖氨酸形式)转化为纤溶酶。
Thromb Res. 1981;23(4-5):411-9. doi: 10.1016/0049-3848(81)90202-4.
9
Stopped-flow fluorescence kinetic studies of Glu-plasminogen. Conformational changes triggered by AH-site ligand binding.谷氨酸纤溶酶原的停流荧光动力学研究。AH 位点配体结合引发的构象变化。
FEBS Lett. 1991 Jan 28;278(2):204-6. doi: 10.1016/0014-5793(91)80117-l.
10
FTIR determination of ligand-induced secondary and tertiary structural changes in bovine plasminogen.傅里叶变换红外光谱法测定配体诱导的牛纤溶酶原二级和三级结构变化
J Dairy Res. 2003 Nov;70(4):461-6. doi: 10.1017/s0022029903006423.

引用本文的文献

1
A High-Throughput Small-Angle X-ray Scattering Assay to Determine the Conformational Change of Plasminogen.一种高通量小角 X 射线散射测定法,用于确定纤溶酶原构象变化。
Int J Mol Sci. 2023 Sep 19;24(18):14258. doi: 10.3390/ijms241814258.
2
Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis.区分纤溶酶原生成的微囊泡:参与纤溶和蛋白水解的微小信使。
Int J Mol Sci. 2023 Jan 13;24(2):1571. doi: 10.3390/ijms24021571.
3
The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
膜联蛋白 A2/钙结合蛋白 S100A10 复合物对致癌性纤溶酶原受体的调控作用。
Biomolecules. 2021 Nov 26;11(12):1772. doi: 10.3390/biom11121772.
4
uPA-mediated plasminogen activation is enhanced by polyphosphate.多聚磷酸盐增强 uPA 介导的纤溶酶原激活。
Haematologica. 2021 Feb 1;106(2):522-531. doi: 10.3324/haematol.2019.237966.
5
The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer.长五聚素(PTX3)作为固有免疫、组织重塑和癌症之间的联系。
Front Immunol. 2019 Apr 4;10:712. doi: 10.3389/fimmu.2019.00712. eCollection 2019.
6
Increased urokinase and consumption of α -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay.纤溶酶原和 α2-抗纤溶酶的消耗增加可解释为何氨甲环酸治疗延迟后获益丧失。
J Thromb Haemost. 2019 Jan;17(1):195-205. doi: 10.1111/jth.14338. Epub 2018 Dec 13.
7
The role of small-angle scattering in structure-based screening applications.小角散射在基于结构的筛选应用中的作用。
Biophys Rev. 2018 Oct;10(5):1295-1310. doi: 10.1007/s12551-018-0464-x. Epub 2018 Oct 10.
8
Lactoferrin is a natural inhibitor of plasminogen activation.乳铁蛋白是纤溶酶原激活的天然抑制剂。
J Biol Chem. 2018 Jun 1;293(22):8600-8613. doi: 10.1074/jbc.RA118.003145. Epub 2018 Apr 18.
9
Biophysical Mechanisms Mediating Fibrin Fiber Lysis.介导纤维蛋白纤维溶解的生物物理机制。
Biomed Res Int. 2017;2017:2748340. doi: 10.1155/2017/2748340. Epub 2017 May 28.
10
Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism.纤溶酶原在催化复合物中与链激酶的快速结合揭示了一种三步机制。
J Biol Chem. 2014 Oct 3;289(40):28006-18. doi: 10.1074/jbc.M114.589077. Epub 2014 Aug 19.